MARSHALL WACE, LLP - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$1,105,248
+61.1%
9,528
+11.2%
0.00%
+100.0%
Q1 2023$686,195
-29.0%
8,571
-29.7%
0.00%
-50.0%
Q4 2022$966,484
-87.3%
12,200
-88.8%
0.00%
-85.7%
Q4 2021$7,592,000
+467.0%
108,511
+323.0%
0.01%
+133.3%
Q3 2021$1,339,000
-41.8%
25,655
-14.0%
0.01%
-45.5%
Q1 2021$2,299,000
+415.5%
29,836
+301.7%
0.01%
+450.0%
Q4 2020$446,0007,4270.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders